Technical Analysis for OBLN - Obalon Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 1.71 3.01% 0.05
OBLN closed up 3.01 percent on Friday, January 18, 2019, on 28 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical OBLN trend table...

Date Alert Name Type % Chg
Jan 18 Stochastic Buy Signal Bullish 0.00%
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Oversold Stochastic Weakness 0.00%
Jan 17 Spinning Top Other 3.01%
Jan 17 Wide Bands Range Expansion 3.01%
Jan 17 Down 3 Days in a Row Weakness 3.01%
Jan 17 Oversold Stochastic Weakness 3.01%
Jan 16 Narrow Range Bar Range Contraction 0.59%
Jan 16 Doji - Bullish? Reversal 0.59%

Older signals for OBLN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients. The Obalon balloon system is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed six months after the first balloon is placed. The Obalon balloon system intends to provide patients and physicians with a reversible and repeatable weight loss solution in an outpatient setting, without altering patient anatomy or requiring surgery. The Company has received Premarket approval (PMA) for its Obalon balloon system based on the results of its United States pivotal clinical trial, referred to as the SMART trial.
Is OBLN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.7
52 Week Low 1.46
Average Volume 316,141
200-Day Moving Average 2.3953
50-Day Moving Average 1.9121
20-Day Moving Average 2.0185
10-Day Moving Average 1.771
Average True Range 0.2306
ADX 25.39
+DI 21.8014
-DI 16.9167
Chandelier Exit (Long, 3 ATRs ) 2.7082
Chandelier Exit (Short, 3 ATRs ) 2.1918
Upper Bollinger Band 2.7259
Lower Bollinger Band 1.3111
Percent B (%b) 0.28
BandWidth 70.091652
MACD Line -0.0731
MACD Signal Line -0.0325
MACD Histogram -0.0407
Fundamentals Value
Market Cap 28.77 Million
Num Shares 16.8 Million
EPS -2.31
Price-to-Earnings (P/E) Ratio -0.74
Price-to-Sales 28.14
Price-to-Book 2.79
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.86
Resistance 3 (R3) 1.86 1.81 1.84
Resistance 2 (R2) 1.81 1.77 1.81 1.83
Resistance 1 (R1) 1.76 1.75 1.79 1.76 1.82
Pivot Point 1.71 1.71 1.72 1.71 1.71
Support 1 (S1) 1.66 1.67 1.69 1.66 1.60
Support 2 (S2) 1.61 1.65 1.61 1.59
Support 3 (S3) 1.56 1.61 1.59
Support 4 (S4) 1.56